Search research articles
Contact Us
Filters
Showing results (321-330 of 451) with videos related to
Page
of 46
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1990
Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro
T Shirasaka, K Murakami, H Ford, et al.
Annals of Emergency Medicine
|
March 25, 2017
Clinical Policy: Critical Issues in the Diagnosis and Management of the Adult Psychiatric Patient in the Emergency Department
, Devorah J Nazarian, Joshua S Broder, et al.
Biochemical Pharmacology
|
July 1, 1986
Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity
D A Cooney, M Dalal, H Mitsuya, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1990
Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection
N R Hartman, R Yarchoan, J M Pluda, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1990
Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro
S Hayashi, D W Norbeck, W Rosenbrook, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 1993
Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosine
G Ahluwalia, D A Cooney, N R Hartman, et al.
Biochemical Pharmacology
|
September 1, 1987
2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV)
V E Marquez, C K Tseng, J A Kelley, et al.
BMC Endocrine Disorders
|
March 11, 2017
The association between biochemical control and cardiovascular risk factors in acromegaly
John D Carmichael, Michael S Broder, Dasha Cherepanov, et al.
American Health & Drug Benefits
|
December 22, 2017
The Cost of Hematopoietic Stem-Cell Transplantation in the United States
Michael S Broder, Tiffany P Quock, Eunice Chang, et al.
Gastroenterology
|
January 1, 1981
Resolution of longstanding protein-losing enteropathy in a patient with intestinal lymphangiectasia after treatment for malignant lymphoma
S Broder, T R Callihan, E S Jaffe, et al.
Page
of 46
Search research articles
Search
Showing results (321-330 of 451) with videos related to
Sort By:
Page
of 46
Proceedings of the National Academy of Sciences of the United States of America
|
December 1, 1990
Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitro
T Shirasaka, K Murakami, H Ford, et al.
Annals of Emergency Medicine
|
March 25, 2017
Clinical Policy: Critical Issues in the Diagnosis and Management of the Adult Psychiatric Patient in the Emergency Department
, Devorah J Nazarian, Joshua S Broder, et al.
Biochemical Pharmacology
|
July 1, 1986
Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity
D A Cooney, M Dalal, H Mitsuya, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1990
Pharmacokinetics of 2',3'-dideoxyadenosine and 2',3'-dideoxyinosine in patients with severe human immunodeficiency virus infection
N R Hartman, R Yarchoan, J M Pluda, et al.
Antimicrobial Agents and Chemotherapy
|
February 1, 1990
Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro
S Hayashi, D W Norbeck, W Rosenbrook, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
March 1, 1993
Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosine
G Ahluwalia, D A Cooney, N R Hartman, et al.
Biochemical Pharmacology
|
September 1, 1987
2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV)
V E Marquez, C K Tseng, J A Kelley, et al.
BMC Endocrine Disorders
|
March 11, 2017
The association between biochemical control and cardiovascular risk factors in acromegaly
John D Carmichael, Michael S Broder, Dasha Cherepanov, et al.
American Health & Drug Benefits
|
December 22, 2017
The Cost of Hematopoietic Stem-Cell Transplantation in the United States
Michael S Broder, Tiffany P Quock, Eunice Chang, et al.
Gastroenterology
|
January 1, 1981
Resolution of longstanding protein-losing enteropathy in a patient with intestinal lymphangiectasia after treatment for malignant lymphoma
S Broder, T R Callihan, E S Jaffe, et al.
Page
of 46